205 related articles for article (PubMed ID: 25156828)
21. Radiofrequency ablation for liver metastasis from gastrointestinal stromal tumor.
Yamanaka T; Takaki H; Nakatsuka A; Uraki J; Fujimori M; Hasegawa T; Sakuma H; Yamakado K
J Vasc Interv Radiol; 2013 Mar; 24(3):341-6. PubMed ID: 23352855
[TBL] [Abstract][Full Text] [Related]
22. Percutaneous radiofrequency ablation for unresectable pulmonary metastases from renal cell carcinoma.
Soga N; Yamakado K; Gohara H; Takaki H; Hiraki T; Yamada T; Arima K; Takeda K; Kanazawa S; Sugimura Y
BJU Int; 2009 Sep; 104(6):790-4. PubMed ID: 19338555
[TBL] [Abstract][Full Text] [Related]
23. Long-term results of radiofrequency ablation in colorectal lung metastases: single center experience.
Yamakado K; Inoue Y; Takao M; Takaki H; Nakatsuka A; Uraki J; Kashima M; Kusunoki M; Shimpo H; Takeda K
Oncol Rep; 2009 Oct; 22(4):885-91. PubMed ID: 19724869
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of radiofrequency ablation and metastasectomy in elderly patients with lung metastases from musculoskeletal sarcomas.
Nakamura T; Matsumine A; Yamakado K; Takao M; Uchida A; Sudo A
J Cancer Res Ther; 2013; 9(2):219-23. PubMed ID: 23771362
[TBL] [Abstract][Full Text] [Related]
25. Radiofrequency ablation as treatment for pulmonary metastasis of colorectal cancer.
Hiraki T; Gobara H; Iguchi T; Fujiwara H; Matsui Y; Kanazawa S
World J Gastroenterol; 2014 Jan; 20(4):988-96. PubMed ID: 24574771
[TBL] [Abstract][Full Text] [Related]
26. Radiofrequency ablation for lung tumors: outcomes, effects on survival, and prognostic factors.
Akhan O; Güler E; Akıncı D; Çiftçi T; Köse IÇ
Diagn Interv Radiol; 2016; 22(1):65-71. PubMed ID: 26611111
[TBL] [Abstract][Full Text] [Related]
27. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study).
Lencioni R; Crocetti L; Cioni R; Suh R; Glenn D; Regge D; Helmberger T; Gillams AR; Frilling A; Ambrogi M; Bartolozzi C; Mussi A
Lancet Oncol; 2008 Jul; 9(7):621-8. PubMed ID: 18565793
[TBL] [Abstract][Full Text] [Related]
28. Risk Factors for Local Progression after Percutaneous Radiofrequency Ablation of Lung Tumors: Evaluation Based on a Review of 147 Tumors.
Yang Q; Qi H; Zhang R; Wan C; Song Z; Zhang L; Fan W
J Vasc Interv Radiol; 2017 Apr; 28(4):481-489. PubMed ID: 28111196
[TBL] [Abstract][Full Text] [Related]
29. Pulmonary radiofrequency ablation in patients with a single lung: feasibility, efficacy, and tolerance.
Hess A; Palussière J; Goyers JF; Guth A; Aupérin A; de Baère T
Radiology; 2011 Feb; 258(2):635-42. PubMed ID: 21273525
[TBL] [Abstract][Full Text] [Related]
30. Lung radiofrequency ablation for the treatment of unresectable recurrent non-small-cell lung cancer after surgical intervention.
Kodama H; Yamakado K; Takaki H; Kashima M; Uraki J; Nakatsuka A; Takao M; Taguchi O; Yamada T; Takeda K
Cardiovasc Intervent Radiol; 2012 Jun; 35(3):563-9. PubMed ID: 21748451
[TBL] [Abstract][Full Text] [Related]
31. Radiofrequency Ablation Using a Multiple-Electrode Switching System for Lung Tumors with 2.0-5.0-cm Maximum Diameter: Phase II Clinical Study.
Kodama H; Yamakado K; Hasegawa T; Fujimori M; Yamanaka T; Takaki H; Uraki J; Nakatsuka A; Sakuma H
Radiology; 2015 Dec; 277(3):895-902. PubMed ID: 26053308
[TBL] [Abstract][Full Text] [Related]
32. Percutaneous High-Energy Microwave Ablation for the Treatment of Pulmonary Tumors: A Retrospective Single-Center Experience.
Egashira Y; Singh S; Bandula S; Illing R
J Vasc Interv Radiol; 2016 Apr; 27(4):474-9. PubMed ID: 26944360
[TBL] [Abstract][Full Text] [Related]
33. Safety and Clinical Outcomes of Percutaneous Radiofrequency Ablation for Intermediate and Large Bone Tumors Using a Multiple-Electrode Switching System: A Phase II Clinical Study.
Nakatsuka A; Yamakado K; Uraki J; Takaki H; Yamanaka T; Fujimori M; Hasegawa T; Sakuma H
J Vasc Interv Radiol; 2016 Mar; 27(3):388-94. PubMed ID: 26723527
[TBL] [Abstract][Full Text] [Related]
34. Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation.
Beland MD; Wasser EJ; Mayo-Smith WW; Dupuy DE
Radiology; 2010 Jan; 254(1):301-7. PubMed ID: 20032160
[TBL] [Abstract][Full Text] [Related]
35. Pneumothorax, pleural effusion, and chest tube placement after radiofrequency ablation of lung tumors: incidence and risk factors.
Hiraki T; Tajiri N; Mimura H; Yasui K; Gobara H; Mukai T; Hase S; Fujiwara H; Iguchi T; Sano Y; Shimizu N; Kanazawa S
Radiology; 2006 Oct; 241(1):275-83. PubMed ID: 16908680
[TBL] [Abstract][Full Text] [Related]
36. Treatment of pulmonary colorectal metastases by radiofrequency ablation.
Petre EN; Jia X; Thornton RH; Sofocleous CT; Alago W; Kemeny NE; Solomon SB
Clin Colorectal Cancer; 2013 Mar; 12(1):37-44. PubMed ID: 23026111
[TBL] [Abstract][Full Text] [Related]
37. Radiofrequency ablation of small lung metastases by a single application of a 2-cm expandable electrode: determination of favorable responders.
Sakurai J; Hiraki T; Mimura H; Gobara H; Fujiwara H; Tajiri N; Sano Y; Kanazawa S
J Vasc Interv Radiol; 2010 Feb; 21(2):231-6. PubMed ID: 20022763
[TBL] [Abstract][Full Text] [Related]
38. Unresectable Adrenal Metastases: Clinical Outcomes of Radiofrequency Ablation.
Hasegawa T; Yamakado K; Nakatsuka A; Uraki J; Yamanaka T; Fujimori M; Miki M; Sasaki T; Sakuma H; Sugimura Y
Radiology; 2015 Nov; 277(2):584-93. PubMed ID: 25997031
[TBL] [Abstract][Full Text] [Related]
39. Radiofrequency ablation for ground-glass opacity-dominant lung adenocarcinoma.
Kodama H; Yamakado K; Hasegawa T; Takao M; Taguchi O; Fukai I; Sakuma H
J Vasc Interv Radiol; 2014 Mar; 25(3):333-9. PubMed ID: 24581457
[TBL] [Abstract][Full Text] [Related]
40. Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer: results in 20 nonsurgical candidates.
Hiraki T; Gobara H; Iishi T; Sano Y; Iguchi T; Fujiwara H; Tajiri N; Sakurai J; Date H; Mimura H; Kanazawa S
J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1306-12. PubMed ID: 17976467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
